Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis. - Wikidata - wikimedia - TriplyDB

Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.

Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.

http://www.wikidata.org/entity/Q38192554

about

A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Estimated Prevalence of Tuberculosis Infection Among a New York City Clinic Population Using Interferon-gamma Release Assays.Comparison study of QuantiFERON test with tuberculin skin testing to diagnose latent tuberculosis infection among nurses working in teaching hospitals of Ahvaz, Iran Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.Recommendations for the diagnosis of pediatric tuberculosis.The Prevalence of Latent Tuberculosis Infection in the United States.Demographics and prevalence of positive QuantiFERON-TB Gold In-Tube test in renal transplant candidates.Tuberculin skin test and QuantiFERON performance, and testing of populations at low risk for tuberculosis infection.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting

P2860

Q28547313-62217EA8-E876-4CAF-834F-946BECA19FF7 Q33792760-8AA6A5FD-A2C2-40A4-8906-8587A142D0D7 Q34802094-21B70CBF-6DD9-438D-9801-110BC7700C5E Q37020642-A0F58690-B59D-4174-A660-5B921BC8262F Q38404818-0BAB799D-6FDA-4B7B-9C1B-3689106CDA68 Q38609947-4C3BF638-3998-4E7F-A70E-D2F210F8FE34 Q40005296-6A0B5DC0-FB3E-4663-AC64-B482A9B15623 Q40358599-42FC2A5F-C41C-4EB0-BF15-D4619C1180AA Q46300325-E016034F-505A-44E0-93C5-3E8FB7B84D3D Q48066031-21FB4801-F8A2-46D1-80E9-68D169523B9E Q58701429-89FEB4C4-482A-4F71-BC25-6B68B872276C

P2860

Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.

http://www.wikidata.org/entity/Q38192554

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Performance of QuantiFERON-TB ...... k of exposure to tuberculosis.

@en

type

label

Performance of QuantiFERON-TB ...... k of exposure to tuberculosis.

@en

prefLabel

Performance of QuantiFERON-TB ...... k of exposure to tuberculosis.

@en

P1433

Q38192554-77C44552-9B93-4C7C-9680-25ED358726E8

P1476

Q38192554-3583075E-A70F-4D17-A2B1-5A1CF375BF69

P2093

Q38192554-13C78D47-875A-4F18-B57F-66F0D1B9DAAE

Q38192554-53BD9A1E-8B98-49CD-ACAE-86D44E7D2148

Q38192554-8F1BB143-373C-4C2F-AFD9-6F4B0142350C

Q38192554-BE977AEE-A150-41A5-B635-01453CD69858

Q38192554-EC3E5EFB-576B-4840-83CE-057E04418AC0

P2860

Q38192554-01726DF8-0E29-4B3F-BCC9-2A61B2F7DA89

Q38192554-0FFC42F0-D130-4405-9C2B-2B8D827A8B46

Q38192554-155CBAE9-63FE-48D1-87FC-ED36555E7A0F

Q38192554-16C82682-DDBA-4384-A95D-AD3A7CCECE20

Q38192554-1D9EE5DE-4573-4C5E-BB98-D63056D9EB4A

Q38192554-2420BD2E-ED11-4E8A-A9F7-1956AC240022

Q38192554-2B5CABBC-40CD-4E88-BE0E-939ADF9981F2

Q38192554-4A2C0DB3-3A79-4FDE-B67F-496609399B0C

Q38192554-4D0FE7F1-4B01-457F-BBA2-E653D1856989

Q38192554-5D177842-E5AD-459C-9404-77A9FD14A755

P304

Q38192554-B8239067-1202-4E40-AED3-1672534AC1FA

P31

Q38192554-E65AD651-257A-428C-A8DF-DE1802C6B204

P356

Q38192554-08739A8C-A807-46E5-B724-63F7804F1575

P407

Q38192554-9DD3920F-3382-492A-8CCB-4CA1069686F3

P433

Q38192554-9B89FB64-D5D1-4F58-AD41-1504FFF87718

P478

Q38192554-C6A16D71-F59E-42FA-9332-C9522072C831

P577

Q38192554-8507618F-3173-4FB0-AB80-210FDF217AB9

P5875

Q38192554-D4B526B0-1176-4D78-90A6-1A57F23A7ECC

P698

Q38192554-D5D14BDB-2800-4FAA-B2CC-1CACAD1F81F5

P356

P1433

Clinical Infectious Diseases

P1476

Performance of QuantiFERON-TB ...... k of exposure to tuberculosis.

@en

P2093

Alexandra C Sheller

http://www.w3.org/2001/XMLSchema#string

David A Pegues

http://www.w3.org/2001/XMLSchema#string

Evelyn B Wiener

http://www.w3.org/2001/XMLSchema#string

Frances S Shofer

http://www.w3.org/2001/XMLSchema#string

Sharon E McMullen

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

Priorities for screening and treatment of latent tuberculosis infection in the United States

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.

The BCG World Atlas: a database of global BCG vaccination policies and practices.

A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements

Discordance among commercially available diagnostics for latent tuberculosis infection.

Reproducibility of QuantiFERON-TB gold in-tube assay.

P304

1260-1266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU119

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260446726

http://www.w3.org/2001/XMLSchema#string

P698

24585559

http://www.w3.org/2001/XMLSchema#string